Annual CFO
-$47.93 M
+$53.59 M+52.79%
December 31, 2023
Summary
- As of February 20, 2025, CNTB annual cash flow from operations is -$47.93 million, with the most recent change of +$53.59 million (+52.79%) on December 31, 2023.
- During the last 3 years, CNTB annual CFO has fallen by -$22.34 million (-87.33%).
- CNTB annual CFO is now -271.56% below its all-time high of -$12.90 million, reached on December 1, 2019.
Performance
CNTB Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
CNTB Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +52.8% | - | - |
3 y3 years | -87.3% | - | - |
5 y5 years | -271.6% | - | - |
CNTB Cash From Operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +52.8% | ||||
5 y | 5-year | -271.6% | +52.8% | ||||
alltime | all time | -271.6% | +52.8% |
Connect Biopharma Holdings Limited Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2023 | -$47.93 M(-52.8%) | - | - |
Dec 2022 | -$101.52 M(+20.4%) | - | - |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$84.32 M(+229.6%) | - | - |
Dec 2020 | -$25.59 M(+98.3%) | - | - |
Dec 2019 | -$12.90 M | - | - |
FAQ
- What is Connect Biopharma Holdings Limited annual cash flow from operations?
- What is the all time high annual CFO for Connect Biopharma Holdings Limited?
- What is Connect Biopharma Holdings Limited annual CFO year-on-year change?
What is Connect Biopharma Holdings Limited annual cash flow from operations?
The current annual CFO of CNTB is -$47.93 M
What is the all time high annual CFO for Connect Biopharma Holdings Limited?
Connect Biopharma Holdings Limited all-time high annual cash flow from operations is -$12.90 M
What is Connect Biopharma Holdings Limited annual CFO year-on-year change?
Over the past year, CNTB annual cash flow from operations has changed by +$53.59 M (+52.79%)